NDC11 55513020621
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55513-0206-21 | 55513-0206 |
| 55513-206-21 | 55513-206 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MVASI | BEVACIZUMAB-AWWB | Amgen, Inc | 0a562b4e-67ce-4bab-852c-d9ee71e55fb8 | 2026-06-23 | Warnings, Adverse reactions | 55513-206-21 55513-206 55513020621 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.